WHO ICTRP trial
A Novel Liver Targeted Testosterone Therapy for Sarcopenia in Androgen Deprived…
ACTRN12616001166460 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting
Key facts
| Trial ID | ACTRN12616001166460 |
|---|---|
| Public title | A Novel Liver Targeted Testosterone Therapy for Sarcopenia in Androgen Deprived Men with Prostate Cancer - A Blinded Randomized Controlled Trial |
| Scientific title | A Novel Liver Targeted Testosterone Therapy for Sarcopenia in Androgen Deprived Men with Prostate Cancer - A Blinded Randomized Controlled Trial |
| Primary sponsor | Metro South Health and Hospital Service |
| Secondary sponsors | Prostate Cancer Foundation Australia |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | Australia |
| Conditions | Prostate Cancer;Sarcopenia;Androgen Deprivation Therapy; Prostate Cancer Sarcopenia Androgen Deprivation Therapy;Metabolic and Endocrine - Other metabolic disorders;Cancer - Prostate;Musculoskeletal - Other muscular and skeletal disorders |
| Interventions | 40mg oral testosterone daily for 6 months Will monitor adherence by patient log and drug packet return |
| Registration date | Aug 26, 2016 |
| Target size | 50 |
| Secondary IDs | nil known |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: